Viridian Therapeutics, Inc.\DE (VRDN) Interest & Investment Income: 2021-2025
Historic Interest & Investment Income for Viridian Therapeutics, Inc.\DE (VRDN) over the last 5 years, with Sep 2025 value amounting to $5.5 million.
- Viridian Therapeutics, Inc.\DE's Interest & Investment Income fell 26.53% to $5.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $28.7 million, marking a year-over-year decrease of 0.42%. This contributed to the annual value of $32.1 million for FY2024, which is 73.10% up from last year.
- As of Q3 2025, Viridian Therapeutics, Inc.\DE's Interest & Investment Income stood at $5.5 million, which was down 15.66% from $6.5 million recorded in Q2 2025.
- Viridian Therapeutics, Inc.\DE's Interest & Investment Income's 5-year high stood at $9.1 million during Q4 2024, with a 5-year trough of $55,000 in Q2 2021.
- For the 3-year period, Viridian Therapeutics, Inc.\DE's Interest & Investment Income averaged around $6.4 million, with its median value being $6.5 million (2025).
- As far as peak fluctuations go, Viridian Therapeutics, Inc.\DE's Interest & Investment Income spiked by 2,399.28% in 2022, and later dropped by 26.53% in 2025.
- Quarterly analysis of 5 years shows Viridian Therapeutics, Inc.\DE's Interest & Investment Income stood at $138,000 in 2021, then soared by 2,399.28% to $3.4 million in 2022, then soared by 60.45% to $5.5 million in 2023, then soared by 63.62% to $9.1 million in 2024, then fell by 26.53% to $5.5 million in 2025.
- Its last three reported values are $5.5 million in Q3 2025, $6.5 million for Q2 2025, and $7.5 million during Q1 2025.